The level of macrophage migration inhibitory factor is negatively correlated with the efficacy of PD-1 blockade immunotherapy combined with chemotherapy as a neoadjuvant therapy for esophageal squamous cell carcinoma

The level of macrophage migration inhibitory factor is negatively correlated with the efficacy of PD-1 blockade immunotherapy combined with chemotherapy as a neoadjuvant therapy for esophageal squamous cell carcinoma

Purpose: This study aimed to screen biomarkers to predict the efficacy of programmed cell death 1 (PD-1) blockade immunotherapy combined with chemotherapy as neoadjuvant therapy for esophageal squamous cell carcinoma (ESCC). Methods: In the first stage of the study, the baseline concentrations of 40...

Full description

Bibliographic Details
Main Authors: Liangliang Wu, Yiming Gao, Shengzhi Xie, Wan Ye, Yasushi Uemura, Rong Zhang, Yanju Yu, Jinfeng Li, Man Chen, Qiyan Wu, Pengfei Cui, Hongyu Liu, Shuai Mu, Yilan Li, Lingxiong Wang, Chunxi Liu, Jiahui Li, Lijun Zhang, Shunchang Jiao, Guoqing Zhang, Tianyi Liu
Format: Article
Language:English
Published: Elsevier 2023-11-01
Series:Translational Oncology
Subjects:
Macrophage migration inhibitory factor (MIF)
Neoadjuvant therapy
Immunotherapy
Esophageal squamous cell carcinoma
Biomarker
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523323001614

Internet

http://www.sciencedirect.com/science/article/pii/S1936523323001614

Similar Items